March 27, 2017 / 2:05 PM / 5 months ago

BRIEF-Diamyd: 30 month results from DIABGAD-1 support effect after partial remission phase

March 27 (Reuters) - DIAMYD MEDICAL AB

* 30 MONTH RESULTS FROM DIABGAD-1 SUPPORT EFFECT AFTER PARTIAL REMISSION PHASE

* SAYS TREATMENT WITH DIABETES VACCINE DIAMYD® IN COMBINATION WITH VITAMIN D AND IBUPROFEN HAS A GOOD SAFETY PROFILE AND NO SERIOUS RELATED SIDE EFFECTS SOURCE TEXT FOR EIKON: FURTHER COMPANY COVERAGE: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below